Lantheus Holdings (LNTH) Assets Average (2015 - 2026)
Lantheus Holdings (LNTH) posted quarterly Assets Average of $2.3 billion for Q1 2026, up 13.34% year-over-year from $2.0 billion in Q1 2025, and up 1.56% quarter-over-quarter from $2.3 billion in Q4 2025.
Lantheus Holdings (LNTH) Assets Average (2015 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Assets Average for 12 consecutive years, with $2.3 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average rose 13.34% year-over-year to $2.3 billion; the TTM figure through Mar 2026 stood at $2.3 billion (up 13.34% YoY), while the FY2025 annual figure was $2.1 billion, up 15.87% from the prior year.
- Assets Average climbed to $2.3 billion in Q1 2026 per LNTH's latest filing, from $2.3 billion in the prior quarter.
- Across five years, Assets Average topped out at $2.3 billion in Q1 2026 and bottomed at $898.5 million in Q1 2022.
- Historically, Assets Average has averaged $1.7 billion across 5 years, with a median of $1.7 billion in 2024.
- Annual changes were most pronounced in 2022 — Assets Average advanced 4.88% — and 2023, when it surged 48.62%.
- Lantheus Holdings' Assets Average stood at $1.2 billion in 2022, then jumped by 31.26% to $1.6 billion in 2023, then rose by 27.02% to $2.0 billion in 2024, then rose by 11.76% to $2.3 billion in 2025, then gained by 1.56% to $2.3 billion in 2026.
- Business Quant data shows LNTH's Assets Average at $2.3 billion in Q1 2026, $2.3 billion in Q4 2025, and $2.2 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 5.97 Bn |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | 2.38 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.38 Bn |
| Mar 31, 2026 | 2.29 Bn |
| Dec 31, 2025 | 2.25 Bn |
| Sep 30, 2025 | 2.20 Bn |
| Jun 30, 2025 | 2.09 Bn |
| Mar 31, 2025 | 2.02 Bn |
| Dec 31, 2024 | 2.01 Bn |
| Sep 30, 2024 | 1.99 Bn |
| Jun 30, 2024 | 1.89 Bn |
| Mar 31, 2024 | 1.74 Bn |
| Dec 31, 2023 | 1.59 Bn |
| Sep 30, 2023 | 1.43 Bn |
| Jun 30, 2023 | 1.34 Bn |
| Mar 31, 2023 | 1.34 Bn |
| Dec 31, 2022 | 1.21 Bn |
| Sep 30, 2022 | 1.05 Bn |
| Jun 30, 2022 | 973.50 Mn |
| Mar 31, 2022 | 898.48 Mn |
| Dec 31, 2021 | 855.80 Mn |
| Sep 30, 2021 | 852.81 Mn |